It is rarely discussed that women have significant difficulties having a vaginal orgasm. The majority of women are unable to experience genuine sexual pleasure or orgasm, dueto cultural pressures. They prefer to ignore this feature in their bodies. In this context, Orgasm Vaccine is one of the most preferred applications for women to reach orgasm in sexual experience and to achieve vaginal stimulation. In general, the effects of the Orgasm Vaccine include significant positive results in terms of organizing a quality and healthy sexual life. It is critical forsolving emotional issues such as sexual reluctance, stressand anxiety during sexual intercourse, especiallyin women.
It is known to be very effective in cases of sexual reluctance and loss of pleasure before or after menopause.
Orgasm Vaccine /O shot , It contributes to the sensation of increased desire by renewing the vaginal tissue. Moreover, the vaccine directly contributes to a significant increase in pleasure during sexual intercourse. Moreover, the vaccination has a significant regulatory impact on women’s sexual lives because it directly contributes to the vagina’s narrowing andthe penis’s contact with the clitoris.
O Shot (‘Orgasm Vaccine’) is the application of PRP (Platelet Rich Plasma) into the clitoris and vagina with a special method.
Women can return to their social life on the same day after O Shot, it does not require restrictions for situations such as bathroom and toilet.
Vagina and intra-clitoris PRP application; It can be used for the treatment of inability to orgasm, sexual reluctance and dyspareunia (painful sexual intercourse), US physician Dr. Charles Runels was claimed it in a pilot study that included 11 patients for the first time. Later, this application was registered by him with the trade name ‘O Shot’ (Orgasm Vaccine).
The clitoris is the most significant female sexual organ. The only known function of the clitoris is that of an erogenous point in female sexuality; it responds equally to both somatogenic and psychogenic forms of stimulation.
The clitoris consists of corpus (body), crus (extensions) and glans (head). It’s the equivalent of a male penis. The lower base tissue of the clitoris is the corpus cavernosum. There are about 8,000 nerve endings in the glans clitoris, which stimulates a huge amount of nerve activity. 90% of women experience orgasm with clitoral stimulation. PRP (O shot) application is used in the treatment of inability to orgasm, sexual reluctance, painful sexual intercourse, vaginal dryness in menopause and pain during sexual intercourse in menopause.
A study has demonstrated that the application of PRP to the clitoris and vagina has a positive impact on sexual functions.
The clitoris is the most significant female sexual organ. The only known function of the clitoris is that of an erogenous point in female sexuality; it responds equally to both somatogenic and psychogenic forms of stimulation.
The clitoris consists of corpus (body), crus (extensions) and glans (head). It’s the equivalent of a male penis. The lower base tissue of the clitoris is the corpus cavernosum. There are about 8,000 nerve endings in the glans clitoris, which stimulates a huge amount of nerve activity. 90% of women experience orgasm with clitoral stimulation. PRP (O shot) application is used in the treatment of inability to orgasm, sexual reluctance, painful sexual intercourse, vaginal dryness in menopause and pain during sexual intercourse in menopause.
A study has demonstrated that the application of PRP to the clitoris and vagina has a positive impact on sexual functions.
A tiny needle is used to inject PRP liquid into the vagina and clitoris during an O Shot procedure. It is a simple and painless process carried out in the clinic.
Up to 15 cc of blood is taken from the person’s own arm. Then, this blood is transferred into a special PRP tube, which contains a sodium citrate derivative anticoagulant. The type of PRP placed in the centrifuge is rotated by centrifugation at 2850 rpm for 9 minutes. (This centrifuge speed and minute may vary depending on the brand of the tube used).
After centrifugation, a red area filled with red blood cells will form at the bottom of the tube and light yellow plasma will form at the top of the tube. The lower 20% of the light colored plasma (close to erythrocytes) is PRP (Platelet Rich Plasma), and the upper 80% is PPP (Platelet Poor Plasma). The valuable part is the platelet and the PRP part, which is rich in growth factors, and this part is applied to the desired areas by being injected with an injector. Occasionally, after being centrifuged twice, the blood taken is ready for injection.
On average, 1.5 cc of PRP is obtained from 15 cc of blood. The most valuable part of PRP is the area closest to the erythrocytes, called the ‘buffy coat’ with its cloudy appearance. It has a white, cloudy appearance due to the white blood cells in the Buffy coat and is the area that shows the mainactivity.
There should be at least 1,000,000/ml platelet in PRP. Increased platelet counts may have a negative impact on wound healing as well as a positive impact. The obtained plasma is placed under ultraviolet light for 10 minutes (photoactivation) as part of the PRP preparation process, which increases the effectiveness of PRP.
With the most recent medical advancements, it has been discovered that the thrombocyte found in PRP is an incredibly effective treatment for tissue regeneration. The growth factors in the platelets increase the production of collagen and begin the healing and regeneration process.
Growth factors in platelets in blood plasma; Growth factors such as PDGF (Platelet derived growth factor), TGF-beta (transforming growth factor beta), EGF (epidermal growth factor) are included in the coverage of PRP. It actively contributes to tissue regeneration, wound healing, and bleeding control. It has been utilized in numerous areas of medicine for this reason, especially in recent years. It has started to be applied frequently in the fields of orthopedics, dentistry, sports medicine, urology, gynecology, dermatology, eye, plastic surgery, anesthesiology and cosmetic medicine.
In the field of cosmetics, it is frequently used, especially for hair transplantation and facial rejuvenation.
There is no need for hospitalization. It is an outpatient procedure.The patient is prepared on the gynecological examination table and local cream can be used to provide mild anesthesia. PRP is made from the patient’s own blood and is applied by using very fine-tipped needles to inject it into the clitoris and its surroundings, the G spot and its surroundings, the vestibulum, the labia minora, and the anterior wall of the vagina. It has been observed that when PRP is applied to this significant area, women’s vaginal stimulation during sexual activity is made easier and they reach orgasm more quickly. The preparation of the procedure does not exceed 10 minutes, and the application does not exceed a few minutes. If necessary, the process can be repeated every 6 months.
After “o shot”, people can return to work and social life on the same day. Does not require restrictions for situations such as bathroom, toilet, sexual intercourse. After the procedure, it’s normal to experience light pinkish bleeding and slight tingling. Painkillers from the paracetamol group can be used when necessary, but they are rarely required. Increased sexual pleasure and orgasmic ease in patients who have O Shot , typically begin 3 weeks after the injection.
No. Since it is prepared in a sterile way from the person’s own blood, the procedure has no risks or side effects.
It can be applied to anyone except menstrual period and pregnancy. It is not performed if there are people with blood clotting diseases, infections and if there is cancer or cancer in the genital area. The PRP procedure for the genital area is also used to treat dry vaginal dryness and lessen menopausal symptoms. The PRP procedure for the genital area is also used to treat dry vaginal dryness and lessen menopausal symptoms.
There are problems of not being able to orgasm in sexual intercourse and sexual reluctance that occurs over time. It can also be used to treat lichen sclerosis disease, treat urinary incontinence, and treat vaginal dryness due to menopause and pain during sexual activity. The application should be repeated 3-5 times at intervals of 4 weeks.
When O-shot applications are made using the proper tube and preparation technique on the right patient group, the level of patient satisfaction is quite high.
1997 yılında Ankara Gazi Üniversitesi Tıp Fakültesini bitirdi. 2000 – 2004 yılları arasında Ankara Zekai Tahir Burak Kadın Sağlığı Eğitim ve Araştırma Hastanesinde ihtisas yaparak Kadın Hastalıkları ve Doğum Uzmanı ünvanını aldı. 2008 yılında Holistik Cinsel Terapi eğitimini tamamladı.
